| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1521113
[patent_doc_number] => 06413975
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Purine derivatives having phosphodiesterase iv inhibition activity'
[patent_app_type] => B1
[patent_app_number] => 09/539571
[patent_app_country] => US
[patent_app_date] => 2000-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26029
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 1711
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413975.pdf
[firstpage_image] =>[orig_patent_app_number] => 09539571
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/539571 | Purine derivatives having phosphodiesterase iv inhibition activity | Mar 30, 2000 | Issued |
| 09/540405 | Use of xanthine derivatives for reducing the pathological hyperreactivity of eosinophilic granulocytes, novel xanthine compounds and process for their preparation | Mar 30, 2000 | Abandoned |
| 09/535900 | Active compound from a sponge | Mar 26, 2000 | Abandoned |
Array
(
[id] => 4304247
[patent_doc_number] => 06251890
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 9/524355
[patent_app_country] => US
[patent_app_date] => 2000-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9479
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251890.pdf
[firstpage_image] =>[orig_patent_app_number] => 524355
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/524355 | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment | Mar 12, 2000 | Issued |
Array
(
[id] => 1595102
[patent_doc_number] => 06384014
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Purified form of streptogramines, preparation of same and pharmaceutical compositions containing them'
[patent_app_type] => B1
[patent_app_number] => 09/522949
[patent_app_country] => US
[patent_app_date] => 2000-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24908
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 524
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/384/06384014.pdf
[firstpage_image] =>[orig_patent_app_number] => 09522949
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/522949 | Purified form of streptogramines, preparation of same and pharmaceutical compositions containing them | Mar 9, 2000 | Issued |
Array
(
[id] => 1515510
[patent_doc_number] => 06420554
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Process for preparation of 3-cephem compound'
[patent_app_type] => B1
[patent_app_number] => 09/485712
[patent_app_country] => US
[patent_app_date] => 2000-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4331
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 338
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420554.pdf
[firstpage_image] =>[orig_patent_app_number] => 09485712
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/485712 | Process for preparation of 3-cephem compound | Feb 28, 2000 | Issued |
Array
(
[id] => 1504813
[patent_doc_number] => 06465650
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids'
[patent_app_type] => B1
[patent_app_number] => 09/506901
[patent_app_country] => US
[patent_app_date] => 2000-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14567
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465650.pdf
[firstpage_image] =>[orig_patent_app_number] => 09506901
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/506901 | Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids | Feb 17, 2000 | Issued |
Array
(
[id] => 4373354
[patent_doc_number] => 06288223
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Process for the selective preparation of Z-isomers of 3-2(substituted vinyl)cephalosporins'
[patent_app_type] => 1
[patent_app_number] => 9/446380
[patent_app_country] => US
[patent_app_date] => 2000-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9787
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 393
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288223.pdf
[firstpage_image] =>[orig_patent_app_number] => 446380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446380 | Process for the selective preparation of Z-isomers of 3-2(substituted vinyl)cephalosporins | Feb 17, 2000 | Issued |
Array
(
[id] => 1393109
[patent_doc_number] => 06545002
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors'
[patent_app_type] => B1
[patent_app_number] => 09/505504
[patent_app_country] => US
[patent_app_date] => 2000-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 21774
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/545/06545002.pdf
[firstpage_image] =>[orig_patent_app_number] => 09505504
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/505504 | Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors | Feb 16, 2000 | Issued |
Array
(
[id] => 1470748
[patent_doc_number] => 06407237
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Crystal forms of 9-substituted hypoxanthine derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/505984
[patent_app_country] => US
[patent_app_date] => 2000-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 5513
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407237.pdf
[firstpage_image] =>[orig_patent_app_number] => 09505984
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/505984 | Crystal forms of 9-substituted hypoxanthine derivatives | Feb 15, 2000 | Issued |
Array
(
[id] => 1491237
[patent_doc_number] => 06417352
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid'
[patent_app_type] => B1
[patent_app_number] => 09/381884
[patent_app_country] => US
[patent_app_date] => 2000-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4314
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/417/06417352.pdf
[firstpage_image] =>[orig_patent_app_number] => 09381884
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/381884 | Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid | Feb 9, 2000 | Issued |
Array
(
[id] => 7605339
[patent_doc_number] => 07115590
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-03
[patent_title] => 'Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 09/913226
[patent_app_country] => US
[patent_app_date] => 2000-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16594
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115590.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913226
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913226 | Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents | Feb 9, 2000 | Issued |
Array
(
[id] => 1433466
[patent_doc_number] => 06340756
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-22
[patent_title] => 'Process for preparing a 2-(2-amino-1, 6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative'
[patent_app_type] => B1
[patent_app_number] => 09/497319
[patent_app_country] => US
[patent_app_date] => 2000-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12901
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/340/06340756.pdf
[firstpage_image] =>[orig_patent_app_number] => 09497319
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/497319 | Process for preparing a 2-(2-amino-1, 6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative | Feb 2, 2000 | Issued |
| 09/497592 | 6,7-Distributed-4-aminopyrido[2,3-D]pyrimidine compounds | Feb 2, 2000 | Abandoned |
| 09/445042 | PRECIPITATION PROCESS OF 7-AMINOCEPHALOSPORANIC ACID (7-ACA) | Feb 2, 2000 | Abandoned |
Array
(
[id] => 1298188
[patent_doc_number] => 06627633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-30
[patent_title] => '6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents'
[patent_app_type] => B2
[patent_app_number] => 09/493790
[patent_app_country] => US
[patent_app_date] => 2000-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30925
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627633.pdf
[firstpage_image] =>[orig_patent_app_number] => 09493790
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/493790 | 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents | Jan 27, 2000 | Issued |
Array
(
[id] => 1426559
[patent_doc_number] => 06504027
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-07
[patent_title] => 'Decarboxylation process for synthesizing carbapenem antibiotics'
[patent_app_type] => B1
[patent_app_number] => 09/487044
[patent_app_country] => US
[patent_app_date] => 2000-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3080
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/504/06504027.pdf
[firstpage_image] =>[orig_patent_app_number] => 09487044
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/487044 | Decarboxylation process for synthesizing carbapenem antibiotics | Jan 18, 2000 | Issued |
Array
(
[id] => 1436003
[patent_doc_number] => 06355646
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-12
[patent_title] => 'Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disorders'
[patent_app_type] => B1
[patent_app_number] => 09/367313
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17327
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/355/06355646.pdf
[firstpage_image] =>[orig_patent_app_number] => 09367313
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/367313 | Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disorders | Dec 21, 1999 | Issued |
Array
(
[id] => 1536747
[patent_doc_number] => 06337396
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Process for preparing crystalline cefadroxil hemihydrate from cefadroxil dimethylformamide solvate'
[patent_app_type] => B1
[patent_app_number] => 09/460452
[patent_app_country] => US
[patent_app_date] => 1999-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 946
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337396.pdf
[firstpage_image] =>[orig_patent_app_number] => 09460452
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/460452 | Process for preparing crystalline cefadroxil hemihydrate from cefadroxil dimethylformamide solvate | Dec 12, 1999 | Issued |
Array
(
[id] => 1441175
[patent_doc_number] => 06335324
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-01
[patent_title] => 'Beta lactam compounds and their use as inhibitors of tryptase'
[patent_app_type] => B1
[patent_app_number] => 09/458847
[patent_app_country] => US
[patent_app_date] => 1999-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50887
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/335/06335324.pdf
[firstpage_image] =>[orig_patent_app_number] => 09458847
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/458847 | Beta lactam compounds and their use as inhibitors of tryptase | Dec 12, 1999 | Issued |
